Given the proposed acquisition of Shockwave Medical by Johnson & Johnson, Shockwave Medical is withdrawing its full year 2024 guidance, previously issued on February 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
334.8 USD | -0.01% | +0.01% | +75.69% |
06-03 | Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000 | CI |
06-03 | Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care | CI |
1st Jan change | Capi. | |
---|---|---|
+75.69% | 12.57B | |
-23.76% | 7.43B | |
+13.12% | 7.04B | |
+17.81% | 5.64B | |
-18.26% | 4.84B | |
+18.27% | 4.22B | |
-23.85% | 3.84B | |
+42.33% | 2.29B | |
+2.97% | 2.11B | |
+11.50% | 2.01B |
- Stock Market
- Equities
- SWAV Stock
- News Shockwave Medical
- Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024